The Measure of Plasma Concentrations Is Crucial in Managing Dabigatran Treatment in Non-Valvular Atrial Fibrillation

被引：0
|
作者：
Iosub, Diana [1 ]
Trotti, Rosa [2 ]
Piovella, Franco [2 ]
机构：
[1] Fdn IRCCS Policlin San Matteo, Pavia, Italy
[2] Fdn IRCCS Ist Neurol Nazl Casimiro Mondino, Pavia, Italy
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation
    Yamashita, Takeshi
    Watanabe, Eiichi
    Ikeda, Takanori
    Shiga, Tsuyoshi
    Kusano, Kengo F.
    Takahashi, Naohiko
    Takahashi, Toshiyuki
    Nozaki, Akira
    Kasao, Masashi
    Fukatsu, Tohru
    Kawamura, Yuichiro
    Komatsu, Takashi
    Matsumoto, Naoki
    Arakawa, Tomoharu
    Sugiura, Atsushi
    Iwao, Tetsu
    Ooie, Tatsuhiko
    JOURNAL OF ARRHYTHMIA, 2014, 30 (06) : 478 - 484
  • [32] ADHERENCE TO RIVAROXABAN, DABIGATRAN, AND APIXABAN FOR STROKE PREVENTION IN INCIDENT, TREATMENT-NAIVE NON-VALVULAR ATRIAL FIBRILLATION
    Brown, J.
    Shewale, A. R.
    Talbert, J.
    VALUE IN HEALTH, 2016, 19 (07) : A638 - A638
  • [33] Patient-Reported Treatment Satisfaction with Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation in China
    Geng, Yan-Ping
    Lan, Di-Hui
    Liu, Nian
    Du, Xin
    Zheng, Danni
    Tang, Ri-Bo
    Long, De-Yong
    Yu, Rong-Hui
    Sang, Cai-Hua
    Bai, Rong
    Jiang, Chen-Xi
    Li, Song-Nan
    Guo, Xue-Yuan
    Wang, Wei
    Xia, Shi-Jun
    Chang, San-Shuai
    Dong, Jian-Zeng
    Chen, Ai-Hua
    Ma, Chang-Sheng
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (10) : 1815 - 1822
  • [34] Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
    Hu, Bo
    Ge, Wen
    Wang, Yuliang
    Zhang, Xiaobin
    Li, Tao
    Cui, Hui
    Qian, Yongjun
    Zhang, Yangyang
    Li, Zhi
    FRONTIERS IN GENETICS, 2021, 12
  • [35] Relationship between plasma dabigatran concentration and activated partial thromboplastin time in Japanese patients with non-valvular atrial fibrillation
    Shimomura, Daiki
    Nakagawa, Yoshihisa
    Kondo, Hirokazu
    Tamura, Toshihiro
    Amano, Masashi
    Hayama, Yukiko
    Onishi, Naoaki
    Tamaki, Yodo
    Miyake, Makoto
    Kaitani, Kazuaki
    Lzumi, Chisato
    Hayashida, Masahiko
    Fukuda, Aya
    Nakamura, Fumihiko
    Kawano, Seiji
    JOURNAL OF ARRHYTHMIA, 2015, 31 (04) : 183 - 188
  • [36] 2 Point Plasma Dabigatran, Rivaroxaban and Apixaban Levels in Patientswith Non-Valvular Atrial Fibrillation: A Single Centre Study
    Lim, M. S. H.
    Tiong, L. L.
    Tan, S. S. N.
    Ku, M. Y.
    Charles, S.
    Ong, T. K.
    Fong, A. Y. Y.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : S26 - S27
  • [37] Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis
    Ali, Ali
    Bailey, Claire
    Abdelhafiz, Ahmed H.
    AGE AND AGEING, 2012, 41 (05) : 681 - 684
  • [38] Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation
    Chan, Yi-Hsin
    Yeh, Yung-Hsin
    Tu, Hui-Tzu
    Kuo, Chi-Tai
    Chang, Shang-Hung
    Wu, Lung-Sheng
    Lee, Hsin-Fu
    See, Lai-Chu
    ONCOTARGET, 2017, 8 (58) : 98898 - 98917
  • [39] Novel Anticoagulants for Non-valvular Atrial Fibrillation
    Xu, Bo
    Whitbourn, Robert
    HEART LUNG AND CIRCULATION, 2012, 21 (08): : 463 - 467
  • [40] Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Thomson, Erin
    Smith, David M.
    Coleman, Craig I.
    Damaraju, C. V.
    Schein, Jeffrey R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (10) : 1831 - 1840
12345